Isosorbide mononitrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for isosorbide mononitrate and what is the scope of freedom to operate?
Isosorbide mononitrate
is the generic ingredient in four branded drugs marketed by Schering Plough, Accord Hlthcare, Actavis Elizabeth, Alkermes Gainesville, Aurobindo Pharma, Chartwell Molecular, Dexcel Ltd, Hikma Intl Pharms, Ivax Sub Teva Pharms, Riconpharma Llc, Shandong, Skyepharma Ag, Strides Pharma, Torrent Pharms, Zydus Hlthcare, Zydus Pharms, Promius Pharma, Ani Pharms, Hikma Pharms, and Omnivium Pharms, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for isosorbide mononitrate. Twenty-five suppliers are listed for this compound.
Summary for isosorbide mononitrate
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 20 |
NDAs: | 23 |
Drug Master File Entries: | 6 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 50 |
Drug Prices: | Drug price trends for isosorbide mononitrate |
What excipients (inactive ingredients) are in isosorbide mononitrate? | isosorbide mononitrate excipients list |
DailyMed Link: | isosorbide mononitrate at DailyMed |
Recent Clinical Trials for isosorbide mononitrate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Al-Azhar University | Early Phase 1 |
Cairo University | Phase 1 |
Suez Canal University | Early Phase 1 |
Pharmacology for isosorbide mononitrate
Drug Class | Nitrate Vasodilator |
Physiological Effect | Vasodilation |
Anatomical Therapeutic Chemical (ATC) Classes for isosorbide mononitrate
US Patents and Regulatory Information for isosorbide mononitrate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 090598-003 | Aug 11, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecular | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 075155-002 | Jan 13, 2000 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ivax Sub Teva Pharms | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 075448-003 | Aug 7, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Zydus Pharms | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 218255-001 | Feb 15, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma | ISOSORBIDE MONONITRATE | isosorbide mononitrate | TABLET, EXTENDED RELEASE;ORAL | 216557-003 | Nov 7, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.